Infants More Susceptible Than Older Children to Severe Illness from Viruses
A new study has found infants are far more vulnerable than older children to severe illness from viruses such as influenza, respiratory syncytial virus (RSV), human metapneumovirus (hMPV) and SARS-CoV-2.
High-Dose Flu Vaccine Significantly Lowers Risk of Developing Alzheimer’s (2026)
A UTHealth study found adults 65 and older had a lower risk of developing Alzheimer’s disease after receiving a high-dose flu vaccine.
Flu Vaccine, Even with Infection, Reduces Risk of Heart Attack and Stroke
The Statens Serum Institut in Copenhagen found that flu vaccines may protect against heart attack and stroke, even if the flu is still developed after vaccination.
Pain-Relieving Drug with Minimal Addictive Properties Discovered
The novel opioid DFNZ shows potential for pain and opioid use disorder without causing depressed breathing.
Study Finds Connection with Inflammation in Autoimmune Diseases and Cancer Risk
Immune-mediated inflammatory disease (IMID) patients have been found to have a high risk of developing cancer, but that risk declines as inflammation decreases.
Study Shows Nasal Spray Protects Against Any Flu Strain
The antibody CR9114 shows promise in combating future flu pandemics as it appears to neutralize any influenza virus.
Researchers Identify How to Destroy Cells That Cause Aging
Researchers at Ben-Gurion University of the Negev in Israel have discovered a way to destroy harmful “senescent” cells that accumulate with age and increase the kind of tissue damage and inflammation that slowly causes life to end.
University of Toledo Receives NIH Funds for Fungal Infection Research
A University of Toledo immunologist has received a federal grant to study how a type of cell unexpectedly discovered in the oral cavity helps the body fight off fungal infections.
Study Finds No Connection Between Antibiotic Use and Autoimmune Disease in Children
A groundbreaking retrospective cohort analysis of more than four million children conducted at Sungkyunkwan University in South Korea offers compelling evidence that there is no significant association between early antibiotic exposure and heightened risk of autoimmune diseases in children.
Argenx Is Conducting a Phase IV Study to Assess Efgartigimod Ph20 SC to Treat Adult CIDP Patients
Argenx is conducting a Phase IV clinical study to evaluate how adults with chronic inflammatory demyelinating polyneuropathy transition from intravenous immune globulin treatment to efgartigimod PH20 SC.